SCHEMBL8553174

SCHEMBL8553174

N#Cc1c(CC(=O)O)nn(-c2ccccc2)c1NC(=O)NS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 6/20 0.43
ALOX5 P09917 6/20 0.43
STS P08842 2/20 0.40
EGFR P00533 2/20 0.39
ERBB2 P04626 2/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
NTRK1 P04629 1/20 0.37
ALDH1A1 P00352 2/20 0.37
PTGS1 P23219 2/20 0.37
PTGS2 P35354 2/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555845 0.91 LMNA (0.47) PTGESALOX5L3MBTL1NTRK1ALDH1A1
SCHEMBL8554369 0.91 GAA (0.46) PTGESALOX5FLT1FLT4KDR
SCHEMBL8556673 0.90 PTGES (0.40) PTGESALOX5STSEGFRERBB2
SCHEMBL7355477 0.89 STS (0.40) PTGESALOX5STSEGFRERBB2
SCHEMBL8557168 0.89 GAA (0.44) PTGESALOX5STSNTRK1ALDH1A1
SCHEMBL8553246 0.87 NTRK1 (0.39) PTGESALOX5FLT1FLT4KDR
SCHEMBL1984012 0.85 NTRK1 (0.48) PTGESALOX5FLT1FLT4KDR
SCHEMBL8552075 0.84 FPR1 (0.41) PTGESALOX5FLT1FLT4KDR
SCHEMBL8556018 0.82 LMNA (0.48) L3MBTL1NTRK1ALDH1A1LMNAKMT2A
SCHEMBL8552919 0.81 FPR1 (0.44) PTGESALOX5L3MBTL1NTRK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885890-A1 SULFONYLUREIDOPYRAZOLE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1998-12-23 EP disclosed